LYLE BERKOWITZ

Lyle Berkowitz, MD, stands as a prominent figure in the healthcare investment landscape, uniquely blending extensive clinical expertise with a keen eye for entrepreneurial innovation. As a General Partner at 2Flo Ventures, Dr. Berkowitz plays a pivotal role in shaping the future of healthcare by identifying, funding, and guiding early-stage technology companies poised for significant impact.

At 2Flo Ventures, Dr. Berkowitz leads investment strategies focused on the most promising advancements in health technology. His role involves not only sourcing and evaluating potential portfolio companies but also providing strategic mentorship, drawing on his firsthand experience as a physician and innovator. 2Flo Ventures is dedicated to investing in solutions that address critical challenges in healthcare, and Dr. Berkowitz's leadership ensures that their portfolio aligns with both clinical needs and market opportunities.

Dr. Berkowitz's investment focus areas are deeply rooted in his vision for a more efficient, accessible, and patient-centric healthcare system. He actively seeks out companies specializing in digital health, artificial intelligence (AI) in healthcare, health information technology (HIT), value-based care models, and solutions that enhance patient engagement and clinical workflow. His particular interest lies in technologies that can truly move the needle, whether by improving diagnostic accuracy, streamlining care delivery, or empowering patients with better tools for managing their health. He believes in leveraging technology to bridge gaps in care, reduce costs, and ultimately improve health outcomes for diverse populations.

Prior to his impactful role at 2Flo Ventures, Dr. Berkowitz built a distinguished career marked by innovation and leadership. A physician by training, he served as the Associate Chief Medical Officer of Innovation at Northwestern Medicine, where he spearheaded numerous initiatives to integrate technology into clinical practice. This experience provided him with invaluable insights into the operational complexities and opportunities within large healthcare systems. He is also a serial entrepreneur, having founded several health tech companies, giving him a profound understanding of the startup journey from conception to scale. His background as an author and thought leader further solidifies his reputation as an authority on healthcare transformation, consistently advocating for the adoption of smart technologies to revolutionize patient care.

While specific notable investments are often attributed to the fund as a whole, Dr. Berkowitz's influence is evident in 2Flo Ventures' portfolio, which features companies developing cutting-edge solutions in areas like remote patient monitoring, AI-powered diagnostics, and platforms for chronic disease management. These investments reflect his commitment to backing ventures that offer scalable, sustainable, and clinically validated improvements to healthcare delivery. His unique perspective as a clinician who understands the practical application of technology makes him an invaluable asset to the startups he supports.

Lyle Berkowitz continues to be a driving force in the health tech investment community, leveraging his diverse background to foster innovation and bring transformative solutions to the forefront of healthcare. His work at 2Flo Ventures exemplifies a dedication to not just investing capital, but investing in a healthier future.